Miri Halperin - Jan 1, 2022 Form 3 Insider Report for Mind Medicine (MindMed) Inc. (MNMD)

Role
Executive President, Director
Signature
/s/ Robert Barrow, Attorney-in-Fact
Stock symbol
MNMD
Transactions as of
Jan 1, 2022
Transactions value $
$0
Form type
3
Date filed
1/13/2022, 05:26 PM
Next filing
Mar 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MNMD Subordinate Voting Shares 675K Jan 1, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MNMD Stock Option (Right to Buy) Jan 1, 2022 Subordinate Voting Shares 2.25M $0.34 Direct F2, F3
holding MNMD Stock Option (Right to Buy) Jan 1, 2022 Subordinate Voting Shares 750K $0.26 Direct F4, F5
holding MNMD Stock Option (Right to Buy) Jan 1, 2022 Subordinate Voting Shares 683K $2.42 Direct F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 525,000 of these shares are represented by restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Subordinate Voting Share of the Issuer. The RSUs shall vest as to 25% on February 27, 2021 and the remainder shall vest in 36 equal monthly installments beginning on March 27, 2021, subject to the Reporting Person providing continuous service to the Issuer on each such foregoing date.
F2 25% of the shares underlying the option vested and became exercisable on August 13, 2021; the remaining shares underlying the option vest and become exercisable in 36 equal monthly installments beginning on September 13, 2021, subject to the Reporting Person providing continuous service to the Issuer on each such date.
F3 The option grant has an exercise price of $0.43 Canadian Dollars. This represents the exercise price in United States Dollars.
F4 The shares underlying the option vest and become exercisable in 36 equal monthly installments beginning on March 27, 2021, subject to the Reporting Person providing continuous service to the Issuer on each such date.
F5 The option grant has an exercise price of $0.33 Canadian Dollars. This represents the exercise price in United States Dollars.
F6 25% of the shares underlying the option shall vest and become exercisable on July 15, 2022; the remaining shares underlying the option shall vest and become exercisable in 36 equal monthly installments beginning on August 15, 2022, subject to the Reporting Person providing continuous service to the Issuer on each such date.
F7 The option grant has an exercise price of $3.08 Canadian Dollars. This represents the exercise price in United States Dollars.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney